Common Stock, Shares, Issued of Grace Therapeutics, Inc. from 31 Mar 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Grace Therapeutics, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Mar 2022 to 31 Dec 2025.
  • Grace Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending 31 Dec 2025 was 15,474,026, a 53% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Grace Therapeutics, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 15,474,026 +5,334,165 +53% 31 Dec 2025 10-Q 12 Feb 2026 2026 Q3
Q3 2025 14,128,562 30 Sep 2025 10-Q 13 Nov 2025 2026 Q2
Q2 2025 13,828,562 30 Jun 2025 10-Q 12 Aug 2025 2026 Q1
Q1 2025 13,718,106 +4,318,702 +46% 31 Mar 2025 10-Q 12 Feb 2026 2026 Q3
Q4 2024 10,139,861 31 Dec 2024 10-Q 13 Feb 2025 2025 Q3
Q1 2024 9,399,404 +1,963,871 +26% 31 Mar 2024 10-K 23 Jun 2025 2025 FY
Q3 2023 1,951,371 24 Sep 2023 10-Q 09 Aug 2024 2024 Q1
Q2 2023 7,435,533 30 Jun 2023 10-Q 11 Aug 2023 2023 Q1
Q1 2023 7,435,533 -36,852,650 -83% 31 Mar 2023 10-K 21 Jun 2024 2024 FY
Q1 2022 44,288,183 31 Mar 2022 10-K 23 Jun 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.